Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.88% | 12.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.88% | 12.35% | |||
| Cost of Revenue | -3.88% | 28.94% | |||
| Gross Profit | -3.88% | 9.82% | |||
| SG&A Expenses | -3.88% | -6.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 3.86% | 19.89% | |||
| Total Operating Expenses | -3.88% | -4.61% | |||
| Operating Income | -3.88% | 139.37% | |||
| Income Before Tax | 3.93% | 88.53% | |||
| Income Tax Expenses | -3.89% | -56.77% | |||
| Earnings from Continuing Operations | 3.91% | 84.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.91% | 84.78% | |||
| EBIT | -3.88% | 139.37% | |||
| EBITDA | -5.23% | 207.08% | |||
| EPS Basic | 0.00% | 86.21% | |||
| Normalized Basic EPS | 0.00% | 87.50% | |||
| EPS Diluted | 0.00% | 86.21% | |||
| Normalized Diluted EPS | 0.00% | 87.50% | |||
| Average Basic Shares Outstanding | 0.00% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||